Non-albuminuric reduced eGFR phenotype in children and adolescents with type 1 diabetes by Di Bonito, Procolo et al.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 7 8 1Contents available at ScienceDirectDiabetes Research
and Clinical Practice
journal homepage: www.elsevier.com/locate/diabresNon-albuminuric reduced eGFR phenotype in
children and adolescents with type 1 diabeteshttps://doi.org/10.1016/j.diabres.2019.07.005
0168-8227/ 2019 Published by Elsevier B.V.
* Corresponding author.
E-mail address: mozzilloenza@gmail.com (E. Mozzillo).Procolo Di Bonito a,b, Enza Mozzillo a,*, Maria Esposito a, Francesco Maria Rosanio a,
Alberto Casertano a, Valentina Fattorusso a, Adriana Franzese a
a Pediatric Diabetes Unit, Department of Translational Medical Science, Section of Pediatrics, Federico II University of Naples, Naples, Italy
bDepartment of Internal Medicine ‘‘S. Maria delle Grazie” Hospital, Pozzuoli (Naples), ItalyA R T I C L E I N F O
Article history:
Received 6 June 2019
Received in revised form
25 June 2019
Accepted 1 July 2019





Type 1 diabetes mellitus
Glomerular filtration rateA B S T R A C T
Aims: To analyze the factors associated with non-albuminuric reduced estimated glomeru-
lar filtration rate (NAeGFR-) phenotype in young people with type 1 diabetes (T1DM).
Methods: In this cross-sectional study were enrolled 140 outpatient diabetic children (age 7–
18 years), consecutively observed in the period 2016–2017. Eighteen subjects with microal-
buminuria (defined as albumin excretion rate  30 mg/24 h) were excluded. Fasting HbA1c,
uric acid (UA), neutrophils and lymphocytes count were recorded. Estimated glomerular fil-
tration rate (eGFR) was calculated using the Schwartz’s bed-side formula and reduced eGFR
was defined by a value <90 mL/min/1.73 m2.
Results: Out of 122 subjects analyzed, 76 (62%) showed normal eGFR and 46 (38%) showed
NAeGFR- phenotype. They were characterized by higher prevalence of male sex (57% vs
33%, p = 0.010), autoimmune diseases (26% vs 12%, p = 0.043), high UA levels (4.0 ± 0.9 vs
3.3 ± 0.9 mg/dl, p < 0.0001) and high Neutrophils/Lymphocytes ratio (1.5 [1.2–2.0] vs 1.3
[1.0–1.8], p = 0.023).
Conclusions: In our population, the prevalence on NAeGFR- phenotype is 38% and it is asso-
ciated with male sex, high levels of UA, presence of other autoimmune diseases and low-
grade inflammation. It should encourage pediatricians to monitor early both eGFR and UA
in order to intercept diabetic youth more likely prone to develop progressive renal
impairment.
 2019 Published by Elsevier B.V.1. Introduction
Diabetic kidney disease (DKD) is a frequent microvascular
complication of type 1 diabetes (T1DM). Commonly, microal-
buminuria is considered both the earliest manifestation of
renal damage and a risk marker of chronic kidney disease
(CKD) and cardiovascular disease [1]. In the last years, it has
been argued that DKD is a heterogeneous entity characterizedby non-albuminuric low eGFR phenotype (<60 mL/
min/1.73 m2) or microalbuminuric phenotype. The prevalence
and the impact of these phenotypes on micro- or macrovas-
cular outcomes has been mainly analyzed in type 2 diabetes
(T2DM) [2,3], but only minimally in type 1 diabetic patients
[4,5] and never in pediatric patients. In adults with T1DM,
the Diabetes Control and Complication Trial (DCCT) primary
cohort showed absence of MA and eGFR < 60 mL/min/1.73 m2
2 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 7 8 1in 50% of participants [6]. This result has been recently con-
firmed by Penno et al. [5]. A recent analysis from the Renal
Insufficiency and Cardiovascular Events (RIACE) study
demonstrated that subjects with T2DM and non-
albuminuric low eGFR phenotype showed a higher mortality
than those with microlbuminuric phenotype, which repre-
sents a higher risk of microvascular complications. This
paper seems to confirm the existence of these two distinct
phenotypes. Since the eGFR impairment starts before the
appearance of microalbuminuria [4] and it is predominantly
linear over time [7], it could be clinically relevant to explore
whether the reduction of eGFR in the absence of microalbu-
minuria is detectable in pediatric age. Therefore, the aim of
this study was to analyze the prevalence of non-
albuminuric reduced eGFR phenotype (NAeGFR-) and its asso-
ciated factors in children and adolescents with type 1
diabetes.
1.1. Subjects, materials and methods
1.1.1. Study groups
Type 1 diabetes children and adolescents (age range 7–
18 years) with disease duration 3–16 years, admitted consecu-
tively at the outpatient pediatric diabetes unit of ‘‘Federico II
University of Naples”, were enrolled from January 2016 to Jan-
uary 2017. The diagnosis of T1DM was based on clinical crite-
ria and the presence of islet cell antibodies. Subjects with
diabetic ketoacidosis in the last year, or infections in the last
6 months were excluded. Ninety-one subjects were treated
with multiple daily injection therapy, while 31 with continu-
ous subcutaneous insulin infusion. Nonewas on therapy with
angiotensin-converting enzyme inhibitors or angiotensin-
receptor blockers. Eleven out 140 subjects received celiac dis-
ease (CD) diagnosis (1 before T1DM diagnosis; 6 at T1DM diag-
nosis; 2 within the first year of T1DM; 2 after 5–8 years).
Fifteen out 140 subjects received Hashimoto’s Thyroiditis
(TAI) diagnosis (8 at T1DM diagnosis; 4 within the first year
of T1DM; 3 after 5–6 years). Two subjects out 140 received both
CD and TAI diagnoses at T1DM onset. All procedures, involv-
ing human participants, were in accordance with the ethical
standards of Helsinki and informed consent has been
obtained by patients and caregivers.
1.1.2. Measurements
Height, weight and waist circumference were measured with
standard methods. Body mass index (BMI) and BMI Z-score
were calculated according to the Centers for Disease Control
and Prevention 2000 standards. Blood pressure was measured
on the right arm using standard procedures. Fasting biochem-
ical data including lipids, uric acid (UA), glycosylated hemo-
globin (HbA1c), microalbuminuria, white blood cells count
and subsets of neutrophils and lymphocytes were analyzed
in centralized laboratory of ‘‘Federico II University”. HbA1c
was measured by HPLC. Microalbuminuria was calculated
using 24-h urinary albumin excretion rate. Creatinine was
measured by kinetic colorimetric Jaffe technique IDMs trace-
able (n. 3L81-32). eGFR was calculated by bed-side Schwartz’s
formula: 0.413  height (cm)/serum creatinine (mg/dl) [8].
Neutrophils to lymphocytes ratio was calculated. The evalua-
tion of complications was assessed according to the interna-tional guidelines [9]. In particular, the evaluation of
retinopathy was performed every two years by an expert oper-
ator. The neuropathy was assessed by specific physical exam-
ination and clinical tests.
1.1.3. Definitions
Prepubertal status was defined as total absence of puberty
signs according to the Tanner stage. Reduced eGFR was
defined by a value < 90 mL/min/1.73 m2 according to interna-
tional guidelines [10]. The absence of MA was defined as
24 h urinary albumin excretion rate < 30 mg [10]. The pres-
ence of other autoimmune diseases (CD and TAI) was
obtained from medical records.
1.1.4. Statistical analysis
Data are expressed as Mean ± SD, or proportions (%), or med-
ian and interquartile range (IQ) and 95% confidence interval
(CI). Given the skewed distribution of triglycerides, neu-
trophils, lymphocytes and N/L ratio, these variables were ana-
lyzed after log-transformation, and expressed as median (IQ)
in text and Table 1. Means were analyzed by Student’s t test.
Chi-square and Fisher’s exact tests were used to compare pro-
portions. Odds ratios and 95% CI were calculated by logistic
regression analysis with backward procedure using NAeGFR-
phenotype as dependent variable. Sex and autoimmunity
were included separately as categorical covariates, UA and
N/L ratio as continuous variables. A p value < 0.05 was consid-
ered statistically significant. Statistical analysis was per-
formed with IBM SPSS Statistics, version 20.0.
1.2. Results
Eighteen MA-positive patients out of 140 participants were
excluded from analysis. The presence of NAeGFR- phenotype
was observed in 46 youth (38%). The characteristics of young
people with and without NAeGFR- phenotype (n = 76, 62%) are
expressed in Table 1. The two groups were similar for age,
duration of diabetes, prepubertal status, HbA1c, lipids, blood
pressure, and daily insulin requirement. None showed values
of eGFR < 60 mL/min/1.73 m2 or signs of retinopathy or neu-
ropathy. Subjects with NAeGFR- phenotype showed higher
prevalence of male sex (p = 0.010), concomitant autoimmune
diseases (p = 0.048), higher levels of UA (p < 0.0001), higher
neutrophil count (p = 0.028) and higher N/L ratio (p = 0.032)
in comparison to subjects with normal eGFR. The duration
of diabetes did not correlate with anthropometric or biochem-
ical variables such as lipids, HbA1c, eGFR, UA and N/L ratio. In
the logistic regression analysis, subjects with NAeGFR- phe-
notype showed a high odds ratio for male gender and addi-
tional autoimmune diseases. Similarly, the Odds Ratio of the
NAeGFR- phenotype was 2.5–2.8 folds greater for each
increase of 1 mg/dl of UA or 1 unit of N/L ratio, independently
of age, duration of diabetes, HbA1c, prepubertal status and
BMI Z-score (Table 2).
1.3. Discussion
This study provides the first evidence that one third of chil-
dren and adolescents with T1DM shows a reduced eGFR in
the absence of microalbuminuria. In our sample, this pheno-
Table 1 – Data of participants according to eGFR categories.
Clinical and biochemical variables eGFR  90 mL/min/1.73 m2 n = 76 eGFR < 90 mL/min/1.73 m2 n = 46 p value
Age at examination (years) 14.2 ± 2.6 14.2 ± 3.4 0.974
Boys n (%) 25 (33) 26 (57) 0.010
Prepubertal status n (%) 6 (8) 7 (15) 0.204
Autoimmune diseases n (%) 9 (12) 12 (26) 0.043
Duration of diabetes (years) 6.8 ± 2.8 6.9 ± 3.4 0.968
BMI (kg/m2) 21.3 ± 3.7 21.9 ± 4.2 0.401
BMI Z-score 0.44 ± 1.0 0.65 ± 0.9 0.275
Waist circumference (cm) 69.3 ± 12.1 70.2 ± 10.2 0.680
HbA1c (mmol/mol) 64.5 ± 10.3 64.2 ± 9.9 0.875
HDL-C (mg/dl) 56.8 ± 11.0 55.2 ± 10.6 0.440
Triglycerides (mg/dl) 63 (53–78) 65 (49–83) 0.767
Daily insulin dose IU/kg 0.79 ± 0.25 0.77 ± 0.27 0.707
Uric acid (mg/dl) 3.3 ± 0.9 4.0 ± 0.9 <0.0001
Neutrophils count (109/l) 3.0 (2.6–4.2) 3.5 (2.9–4.2) 0.028
Lymphocytes count (109/l) 2.4 (2.0–2.7) 2.2 (1.8–2.7) 0.451
Neutrophil/Lymphocyte ratio 1.26 (1.03–1.79) 1.49 (1.18–2.05) 0.032
Systolic blood pressure (mmHg) 110.8 ± 11.5 112.9 ± 12.6 0.349
Diastolic blood pressure (mmHg) 71.8 ± 8.2 72.2 ± 8.5 0.831
eGFR (1.73 m/min/1.73 m2) 103.0 ± 16.6 82.3 ± 6.8 <0.0001
Data are expressed as mean ± SD, n (%), median (IQ range).
Table 2 – Odds ratio (95%CI)* of non-albuminuric low eGFR phenotype for male sex, additional autoimmune diseases and each
increase of 1 unit of UA (mg/dl) or N/L ratio (Log).
OR (95%CI) p value
Male sex 2.65 (1.25–5.64) 0.011
Autoimmune diseases 2.80 (1.06–7.40) 0.038
Uric acid (per 1 mg increase) 2.29 (1.45–3.60) <0.0001
Neutrophil/Lymphocyte ratio (per 1 unit increase) 2.80 (1.24–6.35) 0.013
* Adjusted for age, duration of diabetes, HbA1c, prepubertal status, BMI z-score.
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mation and male sex.
In adults, the presence of albuminuric and NAeGFR- phe-
notype has been demonstrated in T1DM [4,5] and in T2DM,
both in cross-sectional [2] and longitudinal studies [3]. How-
ever the prevalence and the characteristics of NAeGFR- phe-
notype have never been analyzed in young people with
T1DM. In our sample UA is the strongest predictor of such
phenotype, confirming the observations obtained in adults
[4,5]. Usually, high levels of UA are associated with more
advanced stage of CKD, although the relationship between
this metabolite and the glomerular function is still debated.
In our study, the strong association between UA, even in the
normal range, with a mild impairment of glomerular function
in diabetes with short duration, is intriguing. This association
needs further investigations; however, it suggests to perform
a more frequent evaluation of UA in pediatric age, since it is
inexpensive and simple to measure.
Furthermore, we demonstrate for the first time the associ-
ation of NAeGFR- phenotype with low-grade inflammation
and other autoimmune diseases. The association between
high N/L ratio and KDN has been recently observed in T2DM
[9], but never in young people with T1DM. N/L ratio is a mar-
ker of low-grade inflammation. This is in line with a previous
study of Krolewsky et al. who reported an associationbetween eGFR decline and high levels of tumor necrosis factor
receptor [4]. Finally, it might be underlined that these alter-
ations are independent by disease duration and HbA1c.
The association between reduced eGFR and other autoim-
mune disease in young people with T1DM is a new finding. It
is well known that T1DM shares an immuno-genetic back-
ground with other autoimmune diseases such as thyroiditis
and celiac disease. It is possible that the inflammation associ-
ated with the autoimmunity may play a pathogenetic role
[11], however the association between autoimmune diseases,
T1DM and reduced eGFR is not easy to interpret, given the
cross sectional nature of our study. Nevertheless, as a testi-
mony of a possible relationship between T1DM, autoimmune
diseases and glomerular impairment, it is worth mentioning
an our recent study that reported a reduced eGFR in adults
with T1DM and celiac disease as compared to those without
[12].
Limitation of this study is the determination of eGFR based
on levels of creatinine more than Cystatin-C. However, it
should be considered that our observational data were
derived from an unselected population using standard meth-
ods adopted in routine checks. Given the cross-sectional
design of our study, we were not able to demonstrate the cau-
sative role of UA, other autoimmune diseases and low-grade
inflammation in determining NAeGFR- phenotype. This
4 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 7 8 1datum can be only a preliminary observation which needs to
be confirmed by extensive prospective studies.
The strength of our observation is represented, first of all,
by the unexpected high prevalence of NAeGFR- phenotype in
a pediatric population with T1DM. Furthermore, in young
people this particular phenotype can be observed without
interference of drugs and other diabetes complications, as it
is instead observed in adult population.
In conclusion, our study demonstrates that NAeGFR- phe-
notype is detectable in more than 30% of children and adoles-
cents with T1DM and that it is associated with a cluster of
conditions like higher UA, autoimmunity, and low-grade
inflammation. Our study highlights the need for carefully
monitoring eGFR and UA level in pediatric subjects with
T1DM in order to early intercept those more likely prone to
develop progressive renal impairment.
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